Literature DB >> 33488057

Intermammary pilonidal sinus in women. Diagnosis and treatment.

S Ferahman1, T Donmez1, A Surek1, A Orhan2, H Ozcevik3.   

Abstract

BACKGROUND: Globally, the term pilonidal sinus disease (PSD) is most frequently used for lesions in the sacrococcygeal region. The inter-mammary sulcus is a rare location for pilonidal sinus abscesses. Our study examined the causes of inter-mammary PSD (IMPSD), which is rarely seen in the literature and our treatment approach. MATERIAL: We retrospectively analyzed patients referred to our hospital's general surgery clinic between 2012 and 2018. Twelve patients were operated on for IMPSD during these six years. An excision, including all sinus openings, was planned, and a D-shaped incision was performed. Sinus openings and tracts underlying the skin were excised in toto. Subcutaneous flaps were created to shift the incision from the midline plane to reduce the recurrence rate. The minimum duration for the follow-up was 24 months. Eight patients were suffering from polycystic ovary syndrome. Progesterone and testosterone levels of the patients were normal. Prior studies evaluating PSD and hormone levels of female patients showed no correlation.
CONCLUSIONS: IMPSD is a disease that should be kept in mind if induration and abscess in the inter-mammary region are present. The risk of recurrence is high if no proper excision is planned. A D-shaped incision including all sinus tract openings and a midline shift prevented our series' possible recurrences. HIPPOKRATIA 2020, 24(2): 84-87. Copyright 2020, Hippokratio General Hospital of Thessaloniki.

Entities:  

Keywords:  Breast; flap technique; inter-mammary; pilonidal sinus

Year:  2020        PMID: 33488057      PMCID: PMC7811880     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  15 in total

1.  Pilonidal abscess of the breast.

Authors:  Joseph Keighley; Aishah Nadim; David Howlett
Journal:  BMJ Case Rep       Date:  2019-03-31

2.  Hidradenitis suppurativa and polycystic ovarian syndrome: Systematic review and meta-analysis.

Authors:  Kevin Phan; Olivia Charlton; Saxon D Smith
Journal:  Australas J Dermatol       Date:  2019-07-01       Impact factor: 2.875

3.  Practice parameters for the management of pilonidal disease-do no further harm?

Authors:  Dietrich Doll
Journal:  Dis Colon Rectum       Date:  2014-03       Impact factor: 4.585

4.  Investigation of the relationship between serum hormones and pilonidal sinus disease: a cross-sectional study.

Authors:  Z Özkan; N Aksoy; S Emir; B H Kanat; A N Gönen; F M Yazar; A R Çimen
Journal:  Colorectal Dis       Date:  2014-04       Impact factor: 3.788

5.  The role of obesity on the recurrence of pilonidal sinus disease in patients, who were treated by excision and Limberg flap transposition.

Authors:  A Cubukçu; N N Gönüllü; M Paksoy; A Alponat; M Kuru; O Ozbay
Journal:  Int J Colorectal Dis       Date:  2000-06       Impact factor: 2.571

6.  A new minimally invasive treatment of pilonidal sinus disease with the use of a diode laser: a prospective large series of patients.

Authors:  A F Pappas; D K Christodoulou
Journal:  Colorectal Dis       Date:  2018-06-27       Impact factor: 3.788

Review 7.  Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome.

Authors:  Eve J Lowenstein
Journal:  Dermatol Ther       Date:  2006 Jul-Aug       Impact factor: 2.851

Review 8.  The Management of Pilonidal Sinus.

Authors:  Igors Iesalnieks; Andreas Ommer
Journal:  Dtsch Arztebl Int       Date:  2019-01-07       Impact factor: 5.594

Review 9.  Sacrococcygeal pilonidal sinus: historical review, pathological insight and surgical options.

Authors:  S Chintapatla; N Safarani; S Kumar; N Haboubi
Journal:  Tech Coloproctol       Date:  2003-04       Impact factor: 3.781

10.  Obesity, Hypertrichosis and Sex Steroids: Are these Factors Related to the Pilonidal Sinus Disease?

Authors:  Uğur Ekici; Murat Ferhat Ferhatoğlu
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2019-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.